Initial outcomes of using allografts from donation after cardiac death donors for liver transplantation in new south wales

Medical Journal of Australia

Volumn 199, Issue 2, 2013, Pages 104-106

  van der Stelt, Jorieke M ^a   Verran, Deborah J ^b   Deroo, Ronald A ^b   Christine, Hazel ^c   Crawford, Michael ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c NSW Organ and Tissue Donation Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ADULT; ALLOGRAFT; ARTERY OCCLUSION; ARTICLE; AUSTRALIA; BILE LEAKAGE; CHILD; CHOLESTASIS; CLINICAL ARTICLE; DONATION AFTER CARDIAC DEATH; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HEPATIC ARTERY; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; ORGAN DONOR; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; SCHOOL CHILD; TIME OF DEATH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DEATH; DONOR SELECTION; END STAGE LIVER DISEASE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED; NEW SOUTH WALES; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880678674     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.11465     Document Type: Article

References (23)

1. Prakoso E, Verran D, Dilworth P, et al. Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Intern Med J 2010; 40: 619-625.
2. Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 2008; 14: 1694-1707.
3. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a metaanalysis. Ann Surg 2011; 253: 259-264.
4. Abt P, Crawford M, Desai N, et al. Liver transplantation from controlled non-heartbeating donors: an increased incidence of biliary complications. Transplantation 2003; 75: 1659-1663.
5. Sheil AG, Stewart JH, Johnson JR, et al. Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors. Lancet 1969; 2: 917-920.
6. Calne RY. Early days of liver transplantation. Am J Transplant 2008; 8: 1775-1778.
7. Yamamoto S, Wilczek HE, Duraj FF, et al. Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center. Am J Transplant 2010; 10: 602-611.
8. D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Controlled non-heart-beating donors: a potential source of extrarenal organs. Transplant Proc 1995; 27: 707-709.
9. Reich DJ, Munoz SJ, Rothstein KD, et al. Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation 2000; 70: 1159-1166.
10. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995; 27: 2893-2894.
11. Cooper JT, Chin LT, Krieger NR, et al. Donation after cardiac death: the University of Wisconsin experience with renal transplantation. Am J Transplant 2004; 4: 1490-1494.
12. Muiesan P, Girlanda R, Jassem W, et al. Singlecenter experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg 2005; 242: 732-738.
13. Domínguez-Gil B, Haase-Kromwijk B, Van Leiden H, et al. Current situation of donation after circulatory death in European countries. Transpl Int 2011; 24: 676-686.
14. Bernat JL, D'Alessandro AM, Port FK, et al. Report of a National Conference on Donation after cardiac death. Am J Transplant 2006; 6: 281-291.
15. NSW Health. Organ donation after cardiac death: NSW guidelines. Sydney: NSW Health, 2011. http://www.health.nsw.gov.au/policies/gl/2011/GL2011_005.html (accessed Jul 2012).
16. Reich DJ, Mulligan DC, Abt PL, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009; 9: 2004-2011.
17. Hashimoto K, Eghtesad B, Gunasekaran G, et al. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant 2010; 10: 2665-2672.
18. Hong JC, Yersiz H, Kasitamongkol P, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg 2011; 146: 1017-1023.
19. The Transplantation Society of Australia and New Zealand. Organ transplantation from deceased donors: consensus statement on eligibility criteria and allocation protocols. Version 1.1. 23. June 2011. http://www.tsanz.com.au/organallocationprotocols/index.asp (accessed Jul 2012).
20. de Graaf EL, Kench J, Dilworth P, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol 2012; 27: 540-546.
21. Lee KW, Simpkins CE, Montgomery RA, et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006; 82: 1683-1688.
22. Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heartbeating donors. Ann Surg 2004; 239: 87-92.
23. Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011; 253: 817-825.